Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the colon Posts on Medivizor
Navigation Menu

Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the colon Posts on Medivizor

Cetuximab combined with chemotherapy improves the outcomes of patients with advanced colorectal cancer

Cetuximab combined with chemotherapy improves the outcomes of patients with advanced colorectal cancer

Posted by on Jul 11, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of cetuximab (Erbitux) in combination with chemotherapy for the treatment of advanced colorectal cancer (CRC). Researchers suggested that this combined treatment improves the outcomes of patients with CRC. Some background CRC is one of the most common cancers worldwide. Around 15 to 25% of...

Read More

Combined S-1 chemotherapy improves the outcomes of patients with advanced colorectal cancer

Combined S-1 chemotherapy improves the outcomes of patients with advanced colorectal cancer

Posted by on Jul 1, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared two different chemotherapy treatments in metastatic colorectal cancer (mCRC; spread to other parts of the body). Researchers suggested that 24-hour infused irinotecan (Camptosar) plus oral S-1 (Teysuno) chemotherapy and bevacizumab (Avastin) is well tolerated and associated with improved outcomes. Some background...

Read More

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Posted by on May 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the combined treatment with cytokine-induced killer cell (CIKC) immunotherapy and chemotherapy after surgery in colorectal cancer. Researchers suggested that this therapy improves treatment outcomes in patients with colorectal cancer. Some background Colorectal cancer is one of the most common...

Read More

Bevacizumab combined with chemotherapy improves the outcomes of elderly patients with advanced colorectal cancer

Posted by on May 6, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of bevacizumab (Avastin) combined with chemotherapy in elderly patients with advanced colorectal cancer. Researchers suggested that this therapy might be associated with improved outcomes in fit older patients. Some background Colorectal cancer is the third most common cancer...

Read More

FOLFOXIRI plus bevacizumab improve the outcomes of patients with advanced colorectal cancer

Posted by on Apr 25, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared two different types of chemotherapy for patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that FOLFOXIRI plus bevacizumab (Avastin) is associated with better outcomes in these patients. Some background Colorectal cancer is the third most common cancer...

Read More

FOLFOX improves the long-term outcomes of patients with stage 3 colon cancer

Posted by on Apr 18, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the change in outcomes over 10-years in patients with stage 3 colon cancer who received FOLFOX chemotherapy. Researchers suggested that this treatment improved the outcomes of these patients. Some background Colorectal cancer is the third most common cancer diagnosed in both men and women in the US. The...

Read More

TAS-102 plus bevacizumab treatment in patients with metastatic treatment-resistant colorectal cancer

Posted by on Feb 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the safety and effectiveness of TAS-102 (trifluridine-tipiracil) with and without bevacizumab (Avastin) therapy in metastatic colorectal cancer (mCRC). Researchers suggested that this combined therapy might be a good treatment option for patients with advanced CRC. Some background Colorectal cancer is the third...

Read More

Does laparoscopic surgery decrease complications after colorectal cancer surgery?

Posted by on Jan 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated if laparoscopic surgery (LS) is associated with fewer complications in colorectal cancer compared to classic, open surgery. Researchers suggested that LS decreases the odds of having a complication after colorectal cancer surgery.  Some background Colorectal cancer is one of the most common cancer...

Read More

Are intense follow-up programs beneficial for patients with colorectal cancer?

Posted by on Jan 10, 2020 in Colorectal cancer | 0 comments

In a nutshell This study reviewed the effect of follow-up programs on the survival of patients with colorectal cancer. Researchers suggested that intense follow-up programs do not improve the survival of these patients. Some background Colorectal cancer is a commonly diagnosed cancer in the US. Two in three patients will present with the possibly...

Read More

Radiation therapy after surgery improves survival of patients with advanced colon cancer

Posted by on Dec 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of radiation therapy (RT) after surgery in patients with T4 (cancer that has grown outside of the colon outer layer and invades the surrounding tissues) colon cancer. Researchers suggested that RT improved overall survival in these patients. Some background Colorectal cancer is the third...

Read More

Treatment dose optimisation in patients with advanced colorectal cancer treated with regorafenib

Posted by on Sep 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of increasing doses of regorafenib (Stivarga) doses in patients with advanced colorectal cancer. Researchers suggested that this method with increasing doses should be used to assess the optimal dose for each patient. Some background Colorectal cancer is the third most common cancer...

Read More

Looking for participants to test a vaccine for the treatment of advanced colorectal cancer

Posted by on Sep 10, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1b trial is examining the effectiveness and safety of a vaccine treatment, ATP128, in the treatment of advanced colorectal cancer. The main outcome to be measured is the tumor response to the treatment and treatment toxicity. This trial is being conducted in Arizona and California, US. The details Colorectal cancer is the...

Read More